ACC and SVS Announce a United Vascular Registry

February 4, 2021—The American College of Cardiology (ACC) and Society for Vascular Surgery (SVS) announced they have moved to a single vascular registry to harness the strengths of both organizations in improving care and outcomes of patients with vascular disease.

Effective January 1, this registry is operated by SVS as a cobranded Vascular Quality Initiative (VQI) program that is a unique and comprehensive resource for measuring and improving the care provided to a growing population of patients with vascular diseases.

The societies advised that the ACC’s Peripheral Vascular Intervention (PVI) Registry will not enroll new hospitals for 2021 but will now be managed by SVS. The ACC data collection tool will remain open through April 15 to allow sites to complete data entry for Q4 2020 and receive a final 2020 outcomes report. Hospitals will be able to access their historic PVI Registry data through December 31, allowing hospitals time to determine how they would like to store or transfer these past records and reports.

To begin enrollment in the SVS VQI, ACC National Cardiovascular Data Registry (NCDR) participants who have not yet joined may contact the SVS VQI account team at vqi@m2s.com or (603) 298-6717.

According to the ACC and SVS, the new registry collaboration provides greater opportunities to evaluate new and emerging technologies, pharmacologic therapies, and medical and lifestyle management. It also provides a rich source of data for academicians, the FDA, and industry looking to answer scientific questions about patient characteristics and outcomes and the use and effectiveness of different treatments.

“The combined strengths of ACC and SVS provide a clear choice for clinicians, researchers, industry, and the FDA when looking for data on the management of vascular diseases,” said Fred Masoudi, MD. Dr. Masoudi is the ACC NCDR Oversight Committee Chair and Chief Scientific Advisor.

VQI Medical Director Jens Jorgensen, MD, added, “This single registry combines the resources and expertise from both organizations. We have merged the best elements of both registries to create the premier vascular clinical registry. We look forward to working with the ACC and other medical society collaborators to enrich the VQI and improve the care of vascular patients.”

The announcement noted that ACC’s PVI Registry assesses the prevalence, demographics, management, and outcomes of patients undergoing percutaneous treatment for peripheral vascular disease. It began as the CARE Registry in 2006 and expanded its scope in 2014 to include lower extremity vascular catheter-based interventions. To date, the PVI Registry includes patient data from > 200 institutions.

The VQI program began in 2010. It is an expansion of the Vascular Study Group of New England, which originated in 2003. More than 750 centers participate in VQI, which has 14 procedural-based registries encompassing the treatment of arterial and venous disease as well as a disease-based registry collecting data on the medical management of aneurysms, carotid stenosis, and lower extremity arterial occlusive disease.